Deals

nuaxia

12 hours ago3 min read

Vivani Spins Out Brain-Computer Interface Business Through Nasdaq Reverse Merger

nuaxia

3 days ago3 min read

Zymeworks’ $929m bid for Theravance reshapes its revenue base

nuaxia

3 days ago3 min read

Ipsen bets up to $1.75bn on Kartos to strengthen myelofibrosis pipeline

nuaxia

4 days ago3 min read

Merck KGaA Expands Life Sciences Business with $11.3bn Bio-Techne Acquisition

nuaxia

Jun 222 min read

Biogen Expands Immunology Pipeline with Up to $1B Acquisition of RayThera

nuaxia

Jun 223 min read

cAMPfield Launches with $180M to Rewire PDE4 Strategy in IBD

nuaxia

Jun 222 min read

Kardigan Surges on $400M IPO Debut as Cardiovascular Bets Draw Investor Momentum

nuaxia

Jun 213 min read

Merck Expands AI Drug Discovery Push with $510m Protillion Partnership

nuaxia

Jun 203 min read

Vedana launches with $46M to chase the next wave of migraine innovation beyond CGRP therapies

nuaxia

Jun 183 min read

Jazz Amplifies Its Oncology Ambitions with $2.4bn+ AbCellera Antibody Partnership

nuaxia

Jun 112 min read

Lilly Adds Another Alzheimer’s Bet With $1bn Push Into Amyloid Modulation

nuaxia

Jun 103 min read

GSK’s $10.6bn Nuvalent Deal Marks a Shift Back to Late-Stage Oncology Scale Plays

nuaxia

Jun 93 min read

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

nuaxia

Jun 64 min read

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

nuaxia

Jun 53 min read

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

nuaxia

Jun 43 min read

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

nuaxia

May 302 min read

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

nuaxia

May 293 min read

Jardine Matheson Acquires I-MED Radiology Network in $2.4bn Healthcare Imaging Deal

nuaxia

May 262 min read

GHO Capital and CBC Group Merge to Create $21bn Global Healthcare Investment Platform

nuaxia

May 223 min read

Vivani Spins Out Brain-Computer Interface Business Through Nasdaq Reverse Merger

Zymeworks’ $929m bid for Theravance reshapes its revenue base

Ipsen bets up to $1.75bn on Kartos to strengthen myelofibrosis pipeline

Merck KGaA Expands Life Sciences Business with $11.3bn Bio-Techne Acquisition

Biogen Expands Immunology Pipeline with Up to $1B Acquisition of RayThera

cAMPfield Launches with $180M to Rewire PDE4 Strategy in IBD

Kardigan Surges on $400M IPO Debut as Cardiovascular Bets Draw Investor Momentum

Merck Expands AI Drug Discovery Push with $510m Protillion Partnership

Vedana launches with $46M to chase the next wave of migraine innovation beyond CGRP therapies

Jazz Amplifies Its Oncology Ambitions with $2.4bn+ AbCellera Antibody Partnership

Lilly Adds Another Alzheimer’s Bet With $1bn Push Into Amyloid Modulation

GSK’s $10.6bn Nuvalent Deal Marks a Shift Back to Late-Stage Oncology Scale Plays

Breaking the BTK Code: Roche Goes All-In on Degrader Strategy with $2.3B Nurix Deal

ResMed Acquires Noctrix Health for $340m to Expand Beyond Sleep Apnoea

Alnylam and Inceptive Launch $2B AI Partnership to Accelerate RNAi Drug Discovery

Lilly and Ascidian Enter $1.9bn Partnership to Advance RNA Exon Editing in Monogenic Kidney Disease

Innovent Biologics and Pfizer Form $10bn+ Oncology Alliance Across 12 Cancer Programs

Jardine Matheson Acquires I-MED Radiology Network in $2.4bn Healthcare Imaging Deal

GHO Capital and CBC Group Merge to Create $21bn Global Healthcare Investment Platform

Decart Raises $300m to Scale Real-Time AI Infrastructure and World Models